Literature DB >> 9339109

The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey.

A Gürgey1, L Mesci.   

Abstract

Resistance to activated protein C (APC), which is caused by a single point mutation in the gene for factor V, is a common risk factor for thrombosis. In this study, we screened factor V (FV) Leiden mutation in 81 subjects. The mutation in the heterozygous form was found in 7.1 percent of our normal population. This high frequency suggests that screening for the FV mutation should be considered in patients with a family history of thrombosis.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9339109

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN： 0041-4301            Impact factor:   0.552


  10 in total

1.  Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Authors:  Grażyna Adler; Jeremy S C Clark; Beata Loniewska; Ewa Czerska; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Factor V Leiden mutation in Turkish patients with homozygous cystathionine beta-synthase deficiency.

Authors:  H S Kalkanoğlu; T Coşkun; S D Aydoğdu; A Tokatli; A Gürgey
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

3.  Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?

Authors:  Deniz Gokalp; Alpaslan Tuzcu; Mithat Bahceci; Orhan Ayyildiz; Murat Yurt; Yusuf Celik; Gulistan Alpagat
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

4.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

5.  The origin of Eastern European Jews revealed by autosomal, sex chromosomal and mtDNA polymorphisms.

Authors:  Avshalom Zoossmann-Diskin
Journal:  Biol Direct       Date:  2010-10-06       Impact factor: 4.540

6.  Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.

Authors:  Betul Tavil; Fehime Kara; Rezan Topaloglu; Selin Aytac; Sule Unal; Baris Kuskonmaz; Mualla Cetin; Nesrin Besbas; Fatma Gumruk
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

7.  May thrombosis be a cause of congenital extremity absence?

Authors:  Gurkan Genc; Nilgun Erkek Atay; Eda Kepenekli; Nese Yarali
Journal:  Indian J Pediatr       Date:  2007-05       Impact factor: 5.319

8.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

9.  Allele frequency distribution of 1691G >A F5 (which confers Factor V Leiden) across Europe, including Slavic populations.

Authors:  Jeremy S C Clark; Grażyna Adler; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2013-11       Impact factor: 3.240

Review 10.  Premature Myocardial Infarction: A Rising Threat.

Authors:  Meral Kayikcioglu; Hasan Selçuk Ozkan; Burcu Yagmur
Journal:  Balkan Med J       Date:  2022-03-14       Impact factor: 2.021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.